In regenerative therapy for ischemic heart disease, use of both autologous and allogeneic stem cells have been investigated. Autologous cell can be applied without immunosuppression but availability is restricted and cells have been exposed to risk factors and aging.
http://ift.tt/WlGeRF
http://ift.tt/WlGeRF
No comments:
Post a Comment